Clinical trials: Gastrointestinal Reflux
Gastroesophageal Reflux, Esophagus, Barrett
Esophageal Atresia: Metaplasia, Barrett
The frequency of Barrett's esophagus (BE) has increased in adults in the last decades, but BE is rare in children. Esophageal atresia (EA), the most common congenital anomaly affecting the esophagus, predisposes the patient to…
- Trial name
- Oesophagix (NCT02495051)
- Testing
- esophageal biopsies
- Where
- 20 sites in Belgium, Canada and 2 more
- Volunteers
- 120 people
- Sponsor
- University Hospital, Lille
Gastro Esophageal Reflux
Near Focus NBI-Driven Artificial Intelligence for the Diagnosis of Gastro-Oesophageal Reflux Disease
Gastro-oesophageal reflux disease (GORD) is a chronic condition with symptoms arising secondary to the reflux of stomach contents (Vakil et al., 2006).
- Trial name
- NCT04268719
- Testing
- wireless pH capsule recording
- Where
- United Kingdom
- Volunteers
- 76 people
- Sponsor
- King's College Hospital NHS Trust
Gastroesophageal Reflux Disease
Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD
This study will be conducted in order to determine safety and efficacy esomeprazole, lansoprazole and pantoprazole control stomach acid by measuring the stomach acid in men and women of Hispanic origin who have GERD.
- Trial name
- NCT00410592
- Testing
- Esomeprazole 40mg, Pantoprazole 40mg, Lansoprazole 30mg
- Where
- 8 sites in United States, Puerto Rico
- Volunteers
- 90 people
- Sponsor
- AstraZeneca
Venous Reflux, Venous Insufficiency
Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections
Randomized Controlled Trial to determine if the outcomes of sclerotherapy of the ulcer bed alone differ from a combination of ablation and sclerotherapy injections.
- Conditions
- Venous Reflux, Venous Insufficiency, Venous Ulcer, Venous Disease
- Trial name
- NCT05633277
- Testing
- Polidocanol
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- ProMedica Health System
Sedative During Endoscopy
Implementing Virtual Reality (VR) to Reduce Sedation
The study is a prospective pilot patients aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy. Patients are administered minimal sedation (2 mg of Versed and 25 mg of Fentanyl) and are given Virtual…
- Trial name
- NCT06349564
- Testing
- Pico 4 Enterprise headset with noise cancelling headphones
- Where
- United States
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- NYU Langone Health
GERD
High Definition Endoscopy With NBI. Contribution in Patients With Non-erosive Esophagitis
Most patients with symptomatic gastroesophageal reflux disease (GERD) have a normal upper gastrointestinal endoscopy. Attempts have been made to define new endoscopic techniques for identification of abnormalities non detected in…
- Trial name
- NCT03824431
- Testing
- Endoscopic esophageal biopsies
- Volunteers
- 70 people
- Sponsor
- University of Sao Paulo General Hospital
Gastroesophageal Reflux, Hernia, Hiatal
Valvuloplasty as Alternative to Toupet Fundoplication for GERD
This monocenter randomized controlled trial aims to compare postoperative outcomes of a laparoscopic valvuloplasty with a Toupet fundoplication in patients with GERD with a maximum hiatal hernia of 3cm.
- Trial name
- VANTAGE (NCT02625077)
- Testing
- Laparoscopic gastroesophageal valvuloplasty, Laparoscopic Toupet fundoplication
- Where
- Netherlands
- Sponsor
- Meander Medical Center
Cough, GERD
The Utility of Nexium in Chronic Cough and Reflux Disease
The purpose of this research study is to investigate different doses of proton pump inhibitors in reducing cough symptoms felt to be associated with Gastroesophageal reflux disease (GERD).
- Trial name
- NCT00287339
- Testing
- Esomeprazole
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of North Carolina, Chapel Hill
Gastro Esophageal Reflux
Effectiveness of Physiologic Testing in PPI Non-Responders
The prevalence of GERD is estimated to be as high as 20% in the US, and up to 50% remain symptomatic on proton pump inhibitor (PPI) therapy.
- Trial name
- NCT03202537
- Testing
- dexlansoprazole
- Where
- United States
- Volunteers
- 240 people
- Sponsor
- Northwestern University
GERD, Radiofrequency Ablation
the Efficency and Safety of Stretta in GERD
This study evaluated the efficency and safety of the endoscopic radiofrequency procedure(Stretta) in adult gastroesophageal patients.
- Trial name
- NCT03574831
- Testing
- Stretta
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Capital Medical University
Bypass Complication, Obesity
Evaluation of Long-term Adverse Effects of Gastric Bypass in Omega
The omega gastric bypass (OAGB) is developing worldwide as an alternative to the Y gastric bypass (RYGB). Cases of nutrition deficiency after OAGB, in particular protein deficency, are regularly reported in the literature…
- Trial name
- OMEGA10 (NCT04930029)
- Testing
- Ten year evaluation
- Where
- France
- Volunteers
- 320 people
- Sponsor
- University Hospital, Lille
GERD
Sopran - Omeprazole Treatment Versus Surgery
The purpose of this study is to study gastritis, GI symptoms during long term omeprazole treatment
- Trial name
- NCT00256737
- Testing
- Omeprazole
- Where
- 13 sites in Denmark, Finland and 2 more
- Volunteers
- 219 people
- Sponsor
- AstraZeneca
Patients With Persistent Objectified Gastroesophageal Reflux and Reflux-Associated Symptoms Despite PPI-Therapy With 40mg Esomeprazole
High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease
It has been reported that Baclofen is an appropriate tool in the therapeutic management of Gastroesophageal Reflux Disease. To objectify gastroesophageal reflux combined pH-metry/impedance monitoring was applied to patients with…
- Trial name
- NEXBAC (NCT00461604)
- Where
- Germany
- Volunteers
- 40 people
- Sponsor
- Technical University of Munich
Barrett Esophagus, Gastroesophageal Reflux
Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus
The purpose of this research study is to assess how safe, effective (how well it works), and tolerable (to put up with) the drug Zegerid is in reducing reflux episodes in patients who have both gastroesophageal reflux disease…
- Trial name
- NCT01129778
- Testing
- Zegerid (proton pump inhibitor), Bravo pH monitoring
- Where
- United States
- Volunteers
- 27 people
- Sponsor
- Stanford University
Laryngopharyngeal Reflux Symptoms, Laryngopharyngitis Chronic
Kazakh Version of Reflux Symptom Index
Reflux symptoms index (RSI) were developed to identify a clinical index of suspicion for laryngopharyngeal reflux (LPR) in patients with ear, nose, and throat symptoms.
- Conditions
- Laryngopharyngeal Reflux Symptoms, Laryngopharyngitis Chronic, Gastro Esophageal Reflux Disease
- Trial name
- NCT05296655
- Testing
- Reflux Symptom Index Inventory (diagnostic survey), Reflux finding score
- Where
- 2 sites in Kazakhstan
- Volunteers
- 248 people, healthy volunteers welcome
- Sponsor
- Kazakh Medical University of Continuing Education
Barrett Esophagus, Esophageal Neoplasms
Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer
The purpose of this study is to confirm the effectiveness and safety of a new medical device which sprays liquid nitrogen through an upper endoscope (cryotherapy) to treat Barrett's esophagus with high-grade dysplasia and early…
- Conditions
- Barrett Esophagus, Esophageal Neoplasms, Deglutition Disorders, GERD
- Trial name
- NCT00321958
- Testing
- CSA System (CryoSpray AblationTM System), CryoSpray Ablation
- Where
- United States
- Volunteers
- 23 people
- Sponsor
- University of Maryland, Baltimore
Cerebral Palsy, GERD
Placebo Controlled Study of Baclofen for GERD in Children With Cerebral Palsy
Despite the use of proton pump inhibitors and available prokinetics, medical therapy is ineffective in an important number of children with cerbreal palsy (CP) and gastroesophageal reflux disease (GERD), and failure of medical…
- Trial name
- NCT01386255
- Testing
- Baclofen
- Where
- United States
- Sponsor
- Boston Children's Hospital
The Aim of This Study is to Investigate the Frequency and Related Risk Factors of Recurrence, and Quality of Life in Patients With GERD After Treatment With PPI
Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational
Recurrence rate, risk factors for the recurrence, and quality of life in patients with GERD in Korea-an observational study.
- Trial name
- Refresh (NCT01378338)
- Where
- 10 sites in South Korea
- Volunteers
- 855 people
- Sponsor
- AstraZeneca
Gastroesophageal Reflux Disease
A Prospective Randomized Trial Comparing Laparoscopic Nissen Against Anterior Partial Fundoplication in Treating Gastroesophageal Reflux Disease Among Chinese Patients
The aim of this study is to compare the effectiveness of laparoscopic Nissen against anterior partial fundoplication in the control of gastroesophageal reflux disease among Chinese patients Study hypothesis Laparoscopic Nissen is…
- Trial name
- NCT00480285
- Testing
- Laparoscopic Nissen Fundoplication, Laparoscopic anterior partial fundoplication
- Where
- Hong Kong
- Volunteers
- 100 people
- Sponsor
- Chinese University of Hong Kong
GERD
Mechanisms Preventing Pharyngeal Reflux
The overall goal is to define and characterize the manometric characteristics of UES incompetence associated with objectively documented pharyngeal reflux. The investigators will use endoscopic reflux detection as gold standard.
- Trial name
- NCT05696184
- Testing
- Concurrent manometry/impedance/pH with video pharyngo-laryngoscopy, Slow and rapid intra-esophageal infusion
- Where
- United States
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- Medical College of Wisconsin
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.